1. Note for guidance on virus validation studies: the design, contribution and interpretation of studies validating the inactivation and removal of viruses, CPMP/BWP/268/95 final version 2,1996
2. Note for guidance on plasma-derived medicinal products, CPMP/BWP/269/95, rev. 3, London,2001
3. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). Q5A Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin, 1998.
4. Announcement on the marketing authorization on medicinal products. Requirements of validation studies for demonstrating the virus safety of medicinal products derived from human blood or plasma;Fed Gaz,1994
5. Design and analysis of serial limiting dilution assays with small sample sizes;Macken;J Immunol Methods,1999